Results
2445
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,445 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ORCL | US$167.81 | -3.6% | 49.9% | US$469.4b | US$194.64 | PE40.4x | E15.7% | 1.0% | Software | ||
UNH | US$466.42 | -10.9% | -11.5% | US$429.2b | US$637.24 | PE29.8x | E18.8% | 1.8% | Healthcare | ||
JNJ | US$162.30 | 3.9% | 0.3% | US$390.8b | US$168.64 | PE27.8x | E8.4% | 3.1% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.86 | 1.9% | 48.3% | UK£157.5b | UK£9.07 | PB1.1x | E2.0% | 5.9% | Banks | ||
AMD | US$110.84 | -2.0% | -37.2% | US$179.6b | US$148.34 | PE109.5x | E32.0% | n/a | Semiconductors | ||
PFE | US$26.30 | 3.0% | -5.3% | US$149.0b | US$31.18 | PE18.6x | E3.6% | 6.5% | Pharmaceuticals & Biotech | ||
LOW | US$239.17 | -5.0% | 2.8% | US$135.0b | US$282.36 | PE19.8x | E5.8% | 1.9% | Retail | ||
BHP | AU$41.26 | 0.8% | -7.4% | AU$209.3b | AU$44.56 | PE11.7x | E-0.4% | 3.8% | Materials | ||
COP | US$97.94 | 1.7% | -12.2% | US$124.6b | US$129.94 | PE13.5x | E4.5% | 3.2% | Energy | ||
BMY | US$55.83 | 3.6% | 8.1% | US$113.3b | US$61.34 | PS2.3x | E34.4% | 4.4% | Pharmaceuticals & Biotech | ||
TD | CA$85.12 | 0.6% | 4.3% | CA$149.0b | CA$89.47 | PB1.3x | E11.6% | 4.9% | Banks | ||
IBKR | US$218.73 | -6.6% | 105.0% | US$94.7b | US$225.80 | PE31.5x | E2.6% | 0.5% | Diversified Financials | ||
INVE A | SEK 320.40 | 0.9% | 24.8% | SEK 984.5b | SEK 315.00 | PE8.7x | E-48.3% | 1.6% | Diversified Financials | ||
BP. | UK£4.48 | -4.3% | -4.0% | UK£70.1b | UK£4.88 | PE239.4x | E34.5% | 5.7% | Energy | ||
ATCO A | SEK 185.80 | -1.0% | 4.1% | SEK 867.8b | SEK 187.30 | PE30.4x | E7.1% | 1.6% | Capital Goods | ||
CVS | US$63.48 | -3.6% | -17.8% | US$80.0b | US$72.14 | PE17.3x | E14.4% | 4.2% | Healthcare | ||
1299 | HK$58.00 | 3.0% | -10.4% | HK$618.4b | HK$92.77 | PE16.5x | E13.9% | 2.8% | Insurance | ||
ITW | US$264.28 | 2.4% | 1.6% | US$77.6b | US$263.47 | PE22.2x | E1.9% | 2.3% | Capital Goods | ||
GSK | UK£14.29 | -0.4% | -14.6% | UK£58.3b | UK£17.97 | PE22.6x | E18.0% | 4.3% | Pharmaceuticals & Biotech | ||
SPG | US$183.80 | -0.7% | 22.2% | US$69.4b | US$190.56 | PB20.7x | E-0.1% | 4.6% | Real Estate | ||
NAB | AU$35.08 | -14.4% | 3.6% | AU$107.4b | AU$34.03 | PB1.7x | E2.1% | 4.8% | Banks | ||
WBC | AU$31.03 | -10.6% | 19.6% | AU$106.3b | AU$29.59 | PB1.5x | E-0.1% | 4.9% | Banks | ||
CRH | US$100.34 | -7.4% | 26.8% | US$67.9b | US$114.61 | PE19.6x | E9.5% | 1.4% | Materials | ||
CNR | CA$147.94 | 2.7% | -16.7% | CA$92.8b | CA$167.71 | PE20.9x | E7.9% | 2.3% | Transportation |